Xtant Medical Holdings
XTNT
18 hedge funds and large institutions have $4.02M invested in Xtant Medical Holdings in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0.09% more ownership
Funds ownership: 92.24% → 92.33% (+0.09%)
5% less funds holding
Funds holding: 19 → 18 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
93% less capital invested
Capital invested by funds: $54.8M → $4.02M (-$50.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
+$59.2K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.89K |
| 4 |
Renaissance Technologies
New York
|
+$2.78K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$23K |
| 2 |
BlackRock
New York
|
-$12.9K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$8K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$7K |
| 5 |
Morgan Stanley
New York
|
-$5 |
XTNT Hedge Fund Activity: Q2 2022 in Review
18 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2022, worth a combined $4.02M — down 93% from $54.8M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of XTNT and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.
The largest buyer was Crescent Grove Advisors, adding an estimated $59.2K. The largest seller was Virtu Financial, exiting entirely with an estimated $23K sold.
- 18 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2022, down from 19 in Q1 2022.
- Funds reported $4.02M of Xtant Medical Holdings stock for Q2 2022, down 93% quarter-over-quarter.
- 2 funds opened new Xtant Medical Holdings positions in Q2 2022 and 3 closed out, a net change of -1 holder.
- The largest Xtant Medical Holdings buyer in Q2 2022 was Crescent Grove Advisors, an estimated $59.2K added.
- The largest Xtant Medical Holdings seller in Q2 2022 was Virtu Financial, an estimated $23K sold.
Based on aggregated 13F filings for Q2 2022.